Polypharmacy Makes it Even More Imperative to be Aware of Medications' Side Effects and Dangerous Adverse Reactions
Theoretically, medications get better over time to target symptoms while minimizing side effects. The reality is that practitioners MUST remain cognizant of medications' side effects and dangerous adverse reactions. This becomes especially important when polypharmacy seems to be the norm.

This webinar will address some of the medications that have recently been the target of class–action lawsuits around the country. You will receive vital and current information to assist you in exceeding best practice guidelines. With attention devoted to timely issues such as the FDA Black Box Warning regarding suicidal thinking, as well as the Syndrome of Inappropriate Antidiuretic Hormone (SIADH), this webinar is essential for anyone working with clients who take medications.

Course Content

A. Pharmacokinetics
B. Extrapyramidal Side Effects (EPSE)
  1. Categories
  2. Treatment
  3. High-risk categories
C. Serotonin Syndrome (SS)
  1. Medications implicated
  2. Symptoms
  3. Course
  4. Treatment
D. Neuroleptic Malignant Syndrome (NMS)
  1. Medications implicated
  2. Symptoms
  3. Course
  4. Treatment
  5. Case Study
E. Steven Johnson’s Syndrome (SJS)
  1. Medications implicated
  2. Symptoms
  3. Course
  4. Treatment
F. Hyponatremia and Syndrome of Inappropriate Antidiuretic Hormone (SIADH)
  1. Symptoms
  2. Course
  3. Medications implicated
G. Black Box Warning and Suicidality
  1. Definition
  2. Medications implicated
  3. Current theories
H. Black Box Warning and QTc Prolongation
  1. Definition
  2. Medications implicated
I. Risk Evaluation and Mitigation Strategies (REMS)
  1.Definition
  2. Practice Implications